M. Herrero

Oligodendrocytes depend on MCL-1 to prevent spontaneous apoptosis and white matter degeneration

Viktoriya D. Nikolova, O. Elroy-Stein, S. Moy, 2020, Cell Death & Disease.

Leukodystrophy resembling Vanishing White Matter Disease is recapitulated by brain-specific depletion of apoptosis regulator MCL-1

Viktoriya D. Nikolova, O. Elroy-Stein, S. Moy, 2020 .

Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder

J. Millán, AP Gómez-Escribano, R. Vázquez-Manrique, 2022, Mechanisms of Ageing and Development.

The Energy Status of Astrocytes Is the Achilles’ Heel of eIF2B-Leukodystrophy

O. Elroy-Stein, A. Atzmon, M. Herrero, 2021, Cells.

eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes

O. Elroy-Stein, Shir Mandelboum, M. Herrero, 2019, NeuroMolecular Medicine.

Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease

O. Elroy-Stein, T. Geiger, A. Atzmon, 2017, Journal of neurochemistry.

Effective extraction of polyribosomes exposes gene expression strategies in primary astrocytes

O. Elroy-Stein, M. Ehrlich, A. Atzmon, 2023, Nucleic acids research.

Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy

O. Elroy-Stein, H. Senderowitz, A. Atzmon, 2018, Front. Mol. Neurosci..

eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes

O. Elroy-Stein, Shir Mandelboum, M. Herrero, 2019, NeuroMolecular Medicine.